Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-89865)
Received: 21 November 2019
Accepted: 26 March 2020
First Online: 19 May 2020
: H08–00241 from the University of British Columbia Research Ethics Board (Vancouver, Canada).
: Not applicable.
: AJNR, LDL, JMF, CAM, and MS delcare that they have no competing interests. DDS has received research funding from AstraZeneca and Merck and have received honoraria for speaking engagements from AstraZeneca and Boehringer Ingelheim.